The immune activation of the AD is characterized by robust type-2-driven inflammation, orchestrated by multiple cytokines, including, interleukins (IL)-4 and -13, which are regarded as pivotal to AD pathogenesis [5,6]. The gene discussed is IL4; the disease is Alzheimer disease.